Ischemia-reperfusion injury is an important cause of liver damage occurring during surgical
procedures including hepatic resection and liver transplantation, and represents the main …

Ischemia-reperfusion (IR) or reoxygenation injury is the paradoxical exacerbation of cellular
impairment following restoration of blood flow after a period of ischemia during surgical …

Short-term patient and graft outcomes continue to improve after kidney and liver
transplantation, with 1-year survival rates over 80%; however, improving longer-term …

Mesenchymal stem cells (MSCs) have been reported to exert therapeutic effects on
immunoregulation, tissue repair, and regeneration from the bench to the bedside. Increasing …

Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in
women of childbearing age. Adipose mesenchymal stem cells (AMSCs) secrete cytokines …

Liver transplantation has become an immense success; nevertheless, far more recipients
are registered on waiting lists than there are available donor livers for transplantation. High …

Background This study aimed to evaluate the effect of exosomes produced by human-
induced pluripotent stem cell–derived mesenchymal stromal cells (hiPSC-MSCs-Exo) on …

Hepatocyte apoptosis is the main pathophysiological process underlying liver
ischemia/reperfusion (I/R) injury. Mitochondrial abnormalities have a vital role in …

Hepatic ischemia/reperfusion injury (IRI) and associated inflammation contributes to liver
dysfunction and complications after liver surgery and transplantation. Mesenchymal stem …

Critically ill patients often suffer from multiple organ failures involving lung, kidney, liver or
brain. Genomic, proteomic and metabolomic approaches highlight common injury …